Total Payments
$1,770
2024 Payments
$69.10
Companies
13
Transactions
35
Medicare Patients
6,591
Medicare Billing
$4.4M
Payment Breakdown by Category
Food & Beverage$1,770 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,770 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $373.97 | 6 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $252.93 | 3 | $0 (2018) |
| Oculus Surgical Inc. | $170.96 | 2 | $0 (2022) |
| Alcon Vision LLC | $169.86 | 2 | $0 (2023) |
| ABBVIE INC. | $149.65 | 8 | $0 (2024) |
| Alcon Laboratories Inc | $123.86 | 1 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $117.04 | 1 | $0 (2019) |
| Shire North American Group Inc | $102.77 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $84.44 | 1 | $0 (2017) |
| Genentech USA, Inc. | $79.91 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69.10 | 3 | ABBVIE INC. ($37.46) |
| 2023 | $303.98 | 11 | Alcon Vision LLC ($109.34) |
| 2022 | $224.58 | 6 | Oculus Surgical Inc. ($170.96) |
| 2021 | $33.29 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($33.29) |
| 2019 | $375.77 | 4 | Bausch & Lomb, a division of Bausch Health US, LLC ($140.97) |
| 2018 | $460.38 | 6 | Bausch & Lomb, a division of Bausch Health US, LLC ($199.71) |
| 2017 | $303.33 | 3 | Johnson & Johnson Surgical Vision, Inc. ($116.12) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: EYE CARE | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: EYE CARE | ||||||
| 08/23/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/10/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: EYE CARE | ||||||
| 06/21/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/31/2023 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $109.34 | General |
| Category: Ophthalmology | ||||||
| 04/19/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: EYE CARE | ||||||
| 02/21/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/07/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: EYE CARE | ||||||
| 01/30/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/11/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/16/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/16/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: RETINA | ||||||
| 07/25/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: RETINA | ||||||
| 03/09/2022 | Oculus Surgical Inc. | — | Food and Beverage | In-kind items and services | $33.39 | General |
| 03/08/2022 | Oculus Surgical Inc. | — | Food and Beverage | In-kind items and services | $137.57 | General |
| 09/29/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug), PROLENSA | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Ophthalmology | ||||||
| 09/22/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Ophthalmology | ||||||
| 03/29/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $117.04 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 02/09/2019 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $60.52 | General |
| Category: Ophthalmology | ||||||
| 02/01/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $140.97 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,100 | 35,642 | $6.8M | $2.7M |
| 2022 | 16 | 2,481 | 9,082 | $3.7M | $1.5M |
| 2021 | 19 | 714 | 1,024 | $921,142 | $206,628 |
| 2020 | 9 | 296 | 332 | $421,675 | $35,675 |
Total Patients
6,591
Total Services
46,080
Medicare Billing
$4.4M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 228 | 2,144 | $3.0M | $1.5M | 48.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 87 | 27,000 | $2.0M | $782,083 | 39.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 325 | 1,526 | $976,800 | $139,910 | 14.3% |
| 92134 | Imaging of retina | Office | 2023 | 883 | 2,398 | $215,820 | $70,253 | 32.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 21 | 353 | $190,620 | $61,678 | 32.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 517 | 651 | $126,945 | $53,551 | 42.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 312 | 630 | $81,900 | $41,072 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 311 | 449 | $58,370 | $29,709 | 50.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 230 | 230 | $69,000 | $26,531 | 38.5% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 15 | 16 | $54,400 | $13,811 | 25.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 52 | 119 | $17,850 | $6,376 | 35.7% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 12 | 14 | $26,950 | $3,328 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 34 | $6,630 | $3,093 | 46.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 15 | 16 | $14,720 | $1,543 | 10.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 13 | 13 | $3,380 | $1,336 | 39.5% |
| 92250 | Photography of the retina | Office | 2023 | 31 | 32 | $4,800 | $794.91 | 16.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 15 | 17 | $3,910 | $583.16 | 14.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 211 | 1,522 | $2.1M | $1.1M | 50.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 25 | 3,060 | $357,010 | $91,315 | 25.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 290 | 946 | $589,050 | $82,328 | 14.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 27 | 369 | $199,260 | $79,792 | 40.0% |
| 92134 | Imaging of retina | Office | 2022 | 705 | 1,636 | $147,240 | $47,120 | 32.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 289 | 324 | $63,180 | $29,262 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 220 | 220 | $66,000 | $25,326 | 38.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 248 | 370 | $48,100 | $22,868 | 47.5% |
About Collin Ohning
Collin Ohning is a Retina Specialist healthcare provider based in Greenbelt, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992182794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Collin Ohning has received a total of $1,770 in payments from pharmaceutical and medical device companies, with $69.10 received in 2024. These payments were reported across 35 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,770).
As a Medicare-enrolled provider, Ohning has provided services to 6,591 Medicare beneficiaries, totaling 46,080 services with total Medicare billing of $4.4M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Internal Medicine, Ophthalmology
- Location Greenbelt, MD
- Active Since 04/30/2015
- Last Updated 01/08/2020
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1992182794
Products in Payments
- Tecnis 1-piece IOL (Device) $153.21
- OZURDEX (Drug) $149.65
- CyPass (Device) $123.86
- ACTHAR (Biological) $117.04
- NGENUITY (Device) $109.34
- ENVISTA (Device) $107.21
- XIIDRA (Drug) $102.77
- Tecnis Multifocal Family of 1-piece IOLS (Device) $99.72
- AKREOS AO (Device) $84.44
- Vabysmo (Drug) $62.22
- AcrySof (Device) $60.52
- iStent inject Trabecular Micro-Bypass Stent System (Device) $57.24
- EYLEA (Biological) $44.88
- EYLEA HD (Biological) $24.88
- ILUVIEN (Drug) $18.04
- VABYSMO (Drug) $17.69
- LOTEMAX SM (Drug) $17.31
- VISUDYNE (Drug) $15.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.